Benign prostatic hyperplasia (BPH) is a non-malignant enlargement of the prostate gland that commonly affects men over 50 and is a leading cause of lower urinary tract symptoms (LUTS). Symptoms ...

A new research paper was published by Aging (Aging-US) on January 6, 2025, in Volume 17, Issue 1, titled "The profile of oxidative stress markers (arachidonic and linoleic acid derivatives) in ...

Today, the American Urological Association (AUA) released the 2026 Management of Lower Urinary Tract Symptoms (LUTS) Attributed to Benign Prostatic Hyperplasia (BPH) Guideline, providing updated, ...

An enlarged prostate—also known as benign prostatic hyperplasia (BPH)—is a natural sign of aging that affects half of all men over the age of 40. The good news is this condition does not increase your ...

Butterfly Medical, developer of a proprietary non-surgical solution for BPH (benign prostatic hyperplasia), today announced ...

Benign Prostatic Hyperplasia Surgical Treatment Market OverviewThe global benign prostatic hyperplasia surgical treatment ...

Resurge Therapeutics, a clinical-stage urology company, today announced positive clinical results from two studies evaluating ...

DEAR DR. ROACH: I am 79. Two recent tests confirmed that my PSA level was 4.6 ng/mL. Previously, my results were never higher than 1.4 ng/mL. Flomax has been a necessity for me for the past 20 years, ...

Contemporary diagnosis of very low risk prostate cancer in a multi-centered hospital system. Use of the Prostatype P-score to predict adverse pathology (AP) at radical prostatectomy (RP). This is an ...

Treatment with the recently approved, minimally invasive Optilume BPH device improves urinary symptoms while preserving sexual function in men with benign prostatic hyperplasia (BPH), concludes a ...

(Boston)—Lori Lerner, MD, associate professor of urology at Boston University Chobanian & Avedisian School of Medicine, is the recipient of the 2026 Distinguished Contribution Award from the American ...